Recipient
Aspect Biosystems Ltd.Department
National Research Council CanadaAmount
$600.0K
Province
BCType
Contribution
Agreement Number
172-2019-2020-Q3-938664
Purpose
CIIP Korea project 3D Printing Therapy will integrate unique 3D bioprinting technology from Aspect Biosystems Ltd. (Canada) with pluripotent stem cell technology from NEXEL Co., Ltd. (Korea) and tissue engineering technologies from POSTECH (Korea). Together, this international team will create a comprehensive solution for 3D bioprinting implantable cardiac and pancreatic therapeutic tissues containing validated stem cell-derived cells as an important step towards the future treatment of patients with myocardial infarction or Type-1 Diabetes.
Aspect Biosystems Ltd. × National Research Council Canada
16 grants totalling $7.0M
Canadian International Innovation Program
132 grants totalling $54.2M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Feldan Bio inc. | $600.0K | Canadian International Innovation Progra... |
| Optiwave Systems Inc. | $600.0K | Canadian International Innovation Progra... |
| Canadian Health Solutions Inc. | $600.0K | Canadian International Innovation Progra... |
| Precision Microdynamics Inc. | $600.0K | Canadian International Innovation Progra... |
| 7423463 Manitoba Ltd. | $600.0K | Canadian International Innovation Progra... |